Curriculum Vitae

2002-2003 Research Award, Rigel Pharmaceuticals, Analysis of samples from a Phase Ib Randomized, Double-Blind, Placebo-Controlled, Crossover, Single Dose Study of Mast Cell Inhibitor, R926112, in Volunteers with Asymptomatic Seasonal Allergic Rhinitis Subjected to a Nasal Allergen Challenge. ................
................